News
TipRanks on MSN11h
AbbVie’s Promising Phase 3 Study on Upadacitinib for Alopecia AreataAbbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
The study involves testing epcoritamab, administered subcutaneously, in combination with oral and intravenous anti-neoplastic agents. These include drugs like lenalidomide, ibrutinib, and polatuzumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback